ESET researchers have discovered a previously undocumented China-aligned APT group that we named GopherWhisper. The group wields a wide array of tools mostly written in Go, using injectors and loaders ...

To join or not to join a gym: That is the question. If you opt out of building a home gym, you can join a club and have access to more weights and machines. Friends and classes motivate you to keep ...

Ocular Therapeutix (OCUL) is a Strong Buy, driven by the pivotal SOL-1 Phase 3 trial for AXPAXLI™ in wet AMD, with topline results expected Q1 2026. AXPAXLI™ leverages proven science and a de-risked ...

From Ironmouse to IShowSpeed, content creators of all stripes are finding success as streamers. Professional streamers often have elaborate setups that can cost thousands of dollars. You may not use ...

Prince Andrew has announced he will no longer use his title of Duke of York and several royal honours, following ongoing scrutiny of his ties to Jeffrey Epstein and renewed public pressure. Although ...

Oct 10 (Reuters) - Drugmaker Bristol Myers Squibb (BMY.N), opens new tab said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to ...

Drugmaker Bristol-Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to diversify from legacy products facing ...

The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. Pushing deeper into in vivo cell therapies, BMS has agreed to pay $1.5 billion to buy the biotech for a pipeline led by a ...

Bristol Myers Squibb has agreed to buy privately held biotechnology company Orbital Therapeutics for $1.5 billion in cash in a deal that bolsters the drugmaker's cell-therapy portfolio. Bristol Myers ...

As I’ve said before, passwords suck. Microsoft agrees—last year, it announced a goal of getting one billion users to embrace passkeys instead. As part of that effort, setting up a passkey for a ...